NewAmsterdam Pharma Company NAMS Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on trailing twelve months.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's free cash flow yield?
- NewAmsterdam Pharma Company (NAMS) reported free cash flow yield of -3.9% in Q1 2026.
- How has NewAmsterdam Pharma Company's free cash flow yield changed year-over-year?
- NewAmsterdam Pharma Company's free cash flow yield increased by 38.3% year-over-year, from -6.3% to -3.9%.
- What is the long-term trend for NewAmsterdam Pharma Company's free cash flow yield?
- Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's free cash flow yield has grown at a 2.5% compound annual growth rate (CAGR), from -3.4% to -3.7%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.